Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gentile

Showing results (171-180 of 313) with videos related to

Pageof 32
Sort By:
European Journal of Haematology|March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocolFortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
Frontiers in Oncology|September 18, 2023
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapyFortunato Morabito, Carlo Adornetto, Paola Monti, et al.
Cell Reports|March 17, 2021
Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patientsJennifer C Reid, Diana Golubeva, Allison L Boyd, et al.
Cancers|September 13, 2025
CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern ItalyDaniele Caracciolo, Filippo Antonio Canale, Virginia Naso, et al.
Expert Opinion on Investigational Drugs|January 11, 2011
Lenalidomide in the treatment of chronic lymphocytic leukemiaMassimo Gentile, Anna Grazia Recchia, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|December 7, 2010
Janus kinase 2 inhibitors in myeloproliferative disordersEugenio Lucia, Anna Grazia Recchia, Massimo Gentile, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Journal of Medical Virology|July 23, 2020
SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown periodOmbretta Turriziani, Ilaria Sciandra, Laura Mazzuti, et al.
Virus Research|January 8, 2021
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)Carolina Scagnolari, Alessandra Pierangeli, Federica Frasca, et al.
Pathogens (Basel, Switzerland)|November 24, 2022
Common Microbial Genital Infections and Their Impact on the Innate Immune Response to HPV in Cervical CellsMatteo Fracella, Giuseppe Oliveto, Leonardo Sorrentino, et al.
Pageof 32

Showing results (171-180 of 313) with videos related to

Sort By:
Pageof 32
European Journal of Haematology|March 4, 2021
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocolFortunato Morabito, Giovanni Tripepi, Ernesto Vigna, et al.
Frontiers in Oncology|September 18, 2023
Genes selection using deep learning and explainable artificial intelligence for chronic lymphocytic leukemia predicting the need and time to therapyFortunato Morabito, Carlo Adornetto, Paola Monti, et al.
Cell Reports|March 17, 2021
Human pluripotent stem cells identify molecular targets of trisomy 12 in chronic lymphocytic leukemia patientsJennifer C Reid, Diana Golubeva, Allison L Boyd, et al.
Cancers|September 13, 2025
CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern ItalyDaniele Caracciolo, Filippo Antonio Canale, Virginia Naso, et al.
Expert Opinion on Investigational Drugs|January 11, 2011
Lenalidomide in the treatment of chronic lymphocytic leukemiaMassimo Gentile, Anna Grazia Recchia, Ernesto Vigna, et al.
Expert Opinion on Investigational Drugs|December 7, 2010
Janus kinase 2 inhibitors in myeloproliferative disordersEugenio Lucia, Anna Grazia Recchia, Massimo Gentile, et al.
Leukemia Research|March 16, 2017
Clinical relevance of hypogammaglobulinemia, clinical and biologic variables on the infection risk and outcome of patients with stage A chronic lymphocytic leukemiaFrancesca R Mauro, Fortunato Morabito, Iolanda D Vincelli, et al.
Journal of Medical Virology|July 23, 2020
SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown periodOmbretta Turriziani, Ilaria Sciandra, Laura Mazzuti, et al.
Virus Research|January 8, 2021
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19)Carolina Scagnolari, Alessandra Pierangeli, Federica Frasca, et al.
Pathogens (Basel, Switzerland)|November 24, 2022
Common Microbial Genital Infections and Their Impact on the Innate Immune Response to HPV in Cervical CellsMatteo Fracella, Giuseppe Oliveto, Leonardo Sorrentino, et al.
Pageof 32